BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1714236)

  • 1. Treatment of dermatomyositis with intravenous gammaglobulin.
    Lang BA; Laxer RM; Murphy G; Silverman ED; Roifman CM
    Am J Med; 1991 Aug; 91(2):169-72. PubMed ID: 1714236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile dermatomyositis: treatment with intravenous gammaglobulin.
    Collet E; Dalac S; Maerens B; Courtois JM; Izac M; Lambert D
    Br J Dermatol; 1994 Feb; 130(2):231-4. PubMed ID: 7510124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dramatic effects of high-dose intravenous gammaglobulin in each patient with intractable dermatomyositis and polymyositis].
    Morita R; Nakano K; Hirano Y; Izumi T; Hirayama Y; Suzuki H; Shishikura K; Okada N; Osawa M; Fukuyama Y
    No To Hattatsu; 1989 Nov; 21(6):523-8. PubMed ID: 2478176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Coutellier A; Ziza JM; Godeau P
    Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High dosage intravenous gamma globulin therapy in juvenile dermatomyositis].
    Schmidt K; Westenberger-Treumann M; Stadler R
    Hautarzt; 1994 Dec; 45(12):854-7. PubMed ID: 7843965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
    Miura M; Ohki H; Tsuchihashi T; Yamagishi H; Katada Y; Yamada K; Yamashita Y; Sugaya A; Komiyama O; Shiro H
    Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better.
    Bussel JB; Fitzgerald-Pedersen J; Feldman C
    Am J Hematol; 1990 Mar; 33(3):184-8. PubMed ID: 1689103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulin.
    Bussel JB; Haimi JS
    Am J Hematol; 1988 Jun; 28(2):79-84. PubMed ID: 2456012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile dermatomyositis: recognition and treatment.
    Reed AM; Lopez M
    Paediatr Drugs; 2002; 4(5):315-21. PubMed ID: 11994036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of pharmacological treatment of Kawasaki disease.
    Onouchi Z; Kawasaki T
    Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility.
    Sato K; Hara T; Kondo T; Iwao H; Honda S; Ueda K
    Acta Paediatr Scand; 1991 Feb; 80(2):163-6. PubMed ID: 1709770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura.
    Bussel JB; Saal S; Gordon B
    Transfusion; 1988; 28(1):38-41. PubMed ID: 3341064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin.
    Kuroda Y; Takashima H; Ikeda A; Endo C; Neshige R; Kakigi R; Shibasaki H
    J Neurol; 1991 Sep; 238(6):309-14. PubMed ID: 1719141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases.
    Sansome A; Dubowitz V
    Arch Dis Child; 1995 Jan; 72(1):25-8. PubMed ID: 7717731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.
    Furukawa S; Matsubara T; Jujoh K; Sasai K; Nakachi S; Sugawara T; Yabuta K; Kato H
    Eur J Pediatr; 1990 Nov; 150(1):43-7. PubMed ID: 1706665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of juvenile dermatomyositis.
    Stringer E; Feldman BM
    Curr Opin Rheumatol; 2006 Sep; 18(5):503-6. PubMed ID: 16896290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of intravenous gamma globulin for therapy of acute myocarditis.
    Robinson JL; Hartling L; Crumley E; Vandermeer B; Klassen TP
    BMC Cardiovasc Disord; 2005 Jun; 5(1):12. PubMed ID: 15932639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin.
    Bussel JB; Cunningham-Rundles C; Abraham C
    Vox Sang; 1986; 51(4):264-9. PubMed ID: 2432727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
    Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of intravenous immunoglobulins in polymyositis and dermatomyositis. An open trial in 15 patients].
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Degennes C; Ziza JM; Du LT; Godeau P
    Presse Med; 1991 Feb; 20(6):244-9. PubMed ID: 1706860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.